A RETROSPECTIVE COHORT STUDY OF PERSISTENCE & COMPLIANCE TO TREATMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN IN HUNGARY

被引：0
|
作者：
Lakatos, P. [1 ]
Toth, E. [2 ]
Kovacs, E. [2 ]
Lang, Z. [2 ]
Psachoulia, E. [3 ]
Intorcia, M. [3 ]
机构：
[1] Semmelweis Univ, H-1085 Budapest, Hungary
[2] Healthware Consulting Ltd, Budapest, Hungary
[3] Amgen Europe GmbH, Zug, Switzerland
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A449 / A449
页数：1
相关论文
共 50 条
  • [21] Low Persistence with Oral Bisphosphonate Treatment in Portuguese Women with Postmenopausal Osteoporosis
    Torre, Carla
    Guerreiro, Jose
    Mendes, Zilda
    Miranda, Ana
    Canhao, Helena
    Branco, Jaime
    Machado, Manuela
    Ferreira, I.
    Feudjo-Tepie, M.
    Cristino, Joaquim
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 496 - 496
  • [22] Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
    Ringe, J. D.
    Christodoulakos, G. E.
    Mellstroem, D.
    Petto, H.
    Nickelsen, T.
    Marin, F.
    Pavo, I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2677 - 2687
  • [23] Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study
    Vega, Alejandra Villagomez
    Nava, Jorge Ivan Gamez
    Gonzalez, Francisco Ruiz
    Romero, Misael Perez
    Rangel, Walter angel Trujillo
    Arana, Ismael Nuno
    GENES, 2023, 14 (02)
  • [24] Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
    J. Morley
    A. Moayyeri
    L. Ali
    A. Taylor
    M. Feudjo-Tepie
    L. Hamilton
    J. Bayly
    Osteoporosis International, 2020, 31 : 533 - 545
  • [25] Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
    Morley, J.
    Moayyeri, A.
    Ali, L.
    Taylor, A.
    Feudjo-Tepie, M.
    Hamilton, L.
    Bayly, J.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (03) : 533 - 545
  • [26] High persistence over two years with denosumab among postmenopausal women with osteoporosis in France: A prospective cohort study
    Briot, Karine
    Schott, Anne-Marie
    Sanchez, Jean-Philippe
    Chauny, Jean-Vannak
    Samama, Pascale
    Desamericq, Gaelle
    BONE, 2021, 146
  • [27] Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
    Lai, E. C-C
    Lin, T-C
    Lange, J. L.
    Chen, L.
    Wong, I. C. K.
    Sing, C-W
    Cheung, C-L
    Shao, S-C
    Yang, Y-H Kao
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 1155 - 1164
  • [28] Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
    E. C.-C. Lai
    T.-C. Lin
    J. L. Lange
    L. Chen
    I. C. K. Wong
    C.-W. Sing
    C.-L. Cheung
    S.-C. Shao
    Y.-H. Kao Yang
    Osteoporosis International, 2022, 33 : 1155 - 1164
  • [29] PERSISTENCE AND ADHERENCE TO DENOSUMAB FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Parrotta, A.
    Muccari, G.
    De Luca, E.
    Gallo, G.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S287 - S288
  • [30] PERSISTENCE AND ADHERENCE WITH OSTEOPOROSIS MEDICATION AND REFRACTURE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS IN TAIWAN
    Hwang, J.
    Juang, H.
    Chang, C. J.
    Tsai, H. C.
    Chang, K.
    Lin, K. K.
    Zhao, Z.
    VALUE IN HEALTH, 2018, 21 : S82 - S82
12345